According to testing firm AMCI, Tesla’s FSD software can’t drive more than 13 miles without needing intervention.
Goldman Sachs initiates Celldex Therapeutics 9CDLX) at neutral, citing concerns about market opportunity and lack of near-term catalysts. Read more here.
The Beachbody Company (BODI) announces restructuring, including a 33% reduction in workforce, cost savings, and shift to single-level affiliate program.